Yesterday, an FDA advisory panel voted to recommend easing restrictions on BPC-157, a peptide that has gained significant attention among athletes, wellness enthusiasts, and practitioners of regenerative medicine. The recommendation could potentially expand future access to BPC-157 through compounding pharmacies, though the FDA has not yet made a final decision. BPC-157 has developed a devoted following because of claims that it may support tissue repair, recovery, gut health